✦ LIBER ✦

Phase II Study of Continuous Daily Sunitinib Dosing in Patients with Previously Treated Advanced Non–Small-Cell Lung Cancer (NSCLC)

✍ Scribed by G.V. Scagliotti; H.H. Gillenwater; J.R. Brahmer; R. Govindan; R. Rosell; C.P. Belani; J.N. Atkins; L. Tye; R. Chao; M.A. Socinski

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of continuous daily sunit

✍ Novello, S; Scagliotti, G V; Rosell, R; Socinski, M A; Brahmer, J; Atkins, J; Pa 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 304 KB

P-208 A phase II study of J-107088 in pr

✍ Kalmadi, S.R.; Dragnev, K.H.; Lynch, T.J.; Crawford, J.; Xu, Li; Gruia, G.; Riga 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 191 KB

Phase II study of S-1 monotherapy in pat

✍ M. Wada; M. Yamamoto; S. Ryuge; Y. Nagashima; N. Hayashi; S. Maki; S. Otani; K. 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 278 KB

Phase II study of high-dose aclarubicin

✍ Peter Buhl Jensen; Susanne Kornum Larsen; Irene Stilbo 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 230 KB

A phase II study of UFT plus cisplatin (

✍ Nakanishi, Y; Fujita, M; Ninomiya, K; Motohiro, A; Kanegae, H; Osaki, S; Watanab 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 234 KB

A Phase II Study of Eribulin Mesylate (E

✍ Alexander I. Spira; Nicholas O. Iannotti; Michael A. Savin; Marcus Neubauer; Nas 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 350 KB